Saturday, 12 July 2014

Can smelling herbs help you sleep better?

Herbs are known to have sevral benefits. One of them, lavender, is said to aid sleep. Put a few drops on the pillow eac night will help one to reduce anxiety, stress and mood swings and calms the nerves. There are some other herbs which are beneficial as well, namely,
1. Cilantro helps to improve bone strength
2. Basil have anti bacterial properties. It is also anti inflammatory and cures mouth ulcers. Basil leaves are boiled in water which helps to cure sore throat.
3. Parsley is a power house of antioxidants, minerals and vitamins which helps to regulate blood cholesterol levels and prevents constipation.
4. Apart from imparting flavour to food, lemon grass also have antifungal properties and its stems are said to have folic acid content.

Sources- hyderabad times.

Monday, 31 March 2014

CARBOHYDRATE DIGESTION AND OBESITY STRONGLY LINKED


New research indicates that obesity in the general population may be genetically linked to how our bodies digest carbohydrates. The study investigated the relationship between body weight and a gene called AMY1, which is responsible for an enzyme present in our saliva known as salivary amylase. This enzyme is the first to be encountered by food when it enters the mouth, and it begins the process of starch digestion that then continues in the gut.
People usually have two copies of each gene, but in some regions of our DNA there can be variability in the number of copies a person carries, which is known as copy number variation. The number of copies of AMY1 can be highly variable between people, and it is believed that higher numbers of copies of the salivary amylase gene have evolved in response to a shift towards diets containing more starch since prehistoric times.
Researchers from Imperial College London, in collaboration with other international institutions, looked at the number of copies of the gene AMY1 present in the DNA of thousands of people from the UK, France, Sweden and Singapore. They found that people who carried a low number of copies of the salivary amylase gene were at greater risk of obesity.
The chance of being obese for people with less than four copies of the AMY1 gene was approximately eight times higher than in those with more than nine copies of this gene. The researchers estimated that with every additional copy of the salivary amylase gene there was approximately a 20 per cent decrease in the odds of becoming obese.
Professor Philippe Froguel, Chair in Genomic Medicine in the School of Public Health at Imperial College London, and one of the lead authors on the study, said: "I think this is an important discovery because it suggests that how we digest starch and how the end products from the digestion of complex carbohydrates behave in the gut could be important factors in the risk of obesity. Future research is needed to understand whether or not altering the digestion of starchy food might improve someone's ability to lose weight, or prevent a person from becoming obese. We are also interested in whether there is a link between this genetic variation and people's risk of other metabolic disorders such as diabetes, as people with a low number of copies of the salivary amylase gene may also be glucose intolerant."
Previous studies have found rare genetic variations causing extreme forms of obesity, but because they occur in only a small number of people, they explained very little of the differences in body weight we see in the population. On the other hand, research on more common genetic variations that increase risk of obesity in the general population have so far generally found only a modest effect on obesity risk. This study is novel in that it identifies a genetic variation that is both common and has a relatively large effect on the risk of obesity in the general population. The number of copies of the salivary amylase gene is highly variable between people, and so, given this finding, can potentially have a large impact on our individual risk of obesity.
The first step of the study involved the analysis of genetic data from a Swedish family sample of 481 participants, recruited on the basis of sibling-pairs where one was obese and the other non-obese. The researchers used these data to short-list genes whose copy number differences influence body mass index (BMI), and identified the gene coding for the enzyme salivary amylase (AMY1) as the one with the greatest influence on body weight in their analysis. They then investigated the relationship between the number of times the AMY1 gene was repeated on chromosome 1 in each individual and their risk of obesity, by studying approximately 5,000 subjects from France and the UK.
Story Source:
The above story is based on materials provided by Imperial College LondonNote: Materials may be edited for content and length.

Journal Reference:
  1. M. Falchi et al. Low copy number of the salivary amylase gene predisposes to obesityNature Genetics, 2014 DOI: 10.1038/ng.2939

Sunday, 16 March 2014

Sugar: time bomb....

New sugar limits: 26 'mini health time bombs' http://www.telegraph.co.uk/health/healthnews/10680467/New-sugar-limits-26-mini-health-time-bombs.html

Tuesday, 28 January 2014

Early tumor response from stereotactic radiosurgery predicts outcome

The response of a patient with metastatic brain tumors to treatment with stereotactic radiosurgery in the first six-to-twelve weeks can indicate whether follow-up treatments and monitoring are necessary, according to research conducted at the University of North Carolina School of Medicine.
          The study of 52 patients with metastatic brain legions, found that the tumors whose sizes decreased significantly after treatment with stereotactic radiosurgery (SRS) did not resume growth or require additional treatment. The research, conducted by a team led by Matthew G. Ewend, MD, chair of the UNC Department of Neurosurgery and member of the UNC Lineberger Comprehensive Cancer Center, could reduce the need to continually monitor patients who respond well to SRS.
 The volume of the tumors over time was measured to see the outcome, based on what happened in the beginning, what would happen long term.It was that tumors that did not shrink in the beginning were more likely later to be correlated to a patient having a neurological problem or needing steroids. If they did shrink, they were more likely to stay under control long term."
The advent of SRS systems allows physicians to target tumors with precise, high-dose beams of radiation. While the technique is in widespread use, current practice requires repeated check-ups to determine its effectiveness. The results of this study indicate that this monitoring may only be necessary for patients who do not respond favorably within the first six to twelve weeks after SRS treatment.
 few MRIs  scans are necessary afterwards for a good response.
Between 20 and 40 percent of adults with cancer develop brain tumors, which metastasize from cancers elsewhere in the body. The number of brain tumors treated by physicians has increased, as better treatments for the cancers that spawn them increase patient survival. Because of the systemic nature of these cancers, the survival implications of positive early response depend largely on how patients respond to therapy for their initial cancer.
"This is not in a vacuum. Even if you control the brain disease, they can still die of their other disease. With better control of the brain disease, the patients have a better chance of living longer, but it will take both improvements in systemic therapy and brain therapy," said Dr. Ewend.
The UNC study included patients with lung, breast, melanoma and renal cell cancers. It builds on prior research that indicated a similar response in patients with clear cell renal cancer. Dr. Ewend said that future research will need to increase the number of patients to reinforce the results and determine what factors influence positive early response. One possibility for future research is to determine the genetic factors behind tumor response, which will allow researchers to develop a genetic test to help predict a patient's outcome.

Story Source:
The above story is based on materials provided by University of North Carolina School of MedicineNote: Materials may be edited for content and length.

Journal Reference: Suzanne R. Sharpton, Eric K. Oermann, Dominic T. Moore, Eric Schreiber, Riane Hoffman, David E. Morris, Matthew G. Ewend. The Volumetric Response of Brain Metastases After Stereotactic Radiosurgery and Its Post-treatment ImplicationsNeurosurgery, 2014; 74 (1): 9 DOI: 10.1227/NEU.0000000000000190